IL18 and cancer: IL-18 is a pro-inflammatory and immunomodulatory cytokine of the IL-1 family that is converted from an inactive precursor protein (pro-IL18) by caspase-1-induced cleavage of an N-terminal fragment and may have anti-cancer and oncogenic effects depending on the tissue and cellular environment (65, 66).